健世科技-B(09877)：LuX-Valve Plus TRAVEL II一年期临床随访结果于美国华盛顿2024经导管心血管学术大会发布CH Energy Eng (03996) holding shareholder obtained A-share shareholding fund loan support; following Takeda's FRUZAQLA (fruquintinib) sales exceeding 0.2 billion USD, Hutchmed (China) (00013) will receive the first commercial milestone payment.
Important event
CH Energy Eng (03996) holding shareholder received A-share shareholding fund loan support.
Healthcare Tech-B (09877): LuX-Valve Plus TRAVEL II one-year clinical follow-up results will be presented at the 2024 Washington Cardiovascular Academic Conference in the USA.
Takeda's FRUQUAQLA (fruquintinib) sales exceeded 0.2 billion US dollars. hutchmed (china) will receive the first commercial milestone payment.
shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349): Obeticholic acid tablets for the treatment of primary biliary cholangitis obtained the drug application acceptance letter for marketing.
Kolon Life Science-B (06990): The new drug application for the core product Lutetium Yttrium Orthosilicate (SAC-TMT) has been accepted by the National Medical Products Administration.
Financial report data.
COSCO Shipping Holdings (01919) achieved a net income attributable to equity holders of 38.124 billion yuan in the first three quarters, an increase of 72.73% year-on-year.
Li Auto Inc (02015) achieved a record high in the third quarter of auto deliveries with a net income of 2.82 billion yuan, a sequential increase of 156.2%.
huishang bank (03698) announced its performance for the first three quarters, with a net income of 13.3 billion yuan, a year-on-year increase of 6.4%.
Zhejiangexpress (00576) announced its performance in the first three quarters, with a profit attributable to shareholders of 4.128 billion yuan, an increase of 5.2% year-on-year.
CBHB (09668) released its performance for the first three quarters, with a net income of 4.766 billion yuan, a decrease of 4.61% year-on-year.
citic (00267): Citic Limited's net income attributable to shareholders for the first three quarters was 38.291 billion yuan, a decrease of 2.63% year-on-year.
mgm china (02282) reported a net profit of 0.929 billion US dollars in the third quarter, a 14% year-on-year increase.
Bud APAC (01876) had a net income attributable to shareholders of 0.742 billion USD in the first three quarters, a decrease of 15.2% year-on-year.
For more details, please refer to the CITIC Securities website ().
